(R)-N-(5,12-dihydroxy-2-(2-methyl-1,3-dioxolan-2-yl)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)acetamide

95%

Reagent Code: #84517
fingerprint
CAS Number 86264-76-8

science Other reagents with same CAS 86264-76-8

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 437.44 g/mol
Formula C₂₄H₂₃NO₇
badge Registry Numbers
MDL Number MFCD18072725
inventory_2 Storage & Handling
Storage 2-8°C

description Product Description

This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of anticancer agents. Its structure is designed to interact with DNA, making it effective in targeting and inhibiting the growth of cancer cells. The compound is often studied for its potential to induce apoptosis in tumor cells, making it a candidate for chemotherapeutic applications. Additionally, it is explored for its ability to enhance the efficacy of other anticancer drugs when used in combination therapies. Research is ongoing to optimize its pharmacokinetic properties and reduce potential side effects, aiming to develop a more targeted and efficient treatment option for various types of cancer.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 250mg
10-20 days ฿27,000.00
inventory 100mg
10-20 days ฿13,500.00
inventory 1g
10-20 days ฿54,000.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
(R)-N-(5,12-dihydroxy-2-(2-methyl-1,3-dioxolan-2-yl)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl)acetamide
No image available
This compound is primarily utilized in the field of medicinal chemistry, particularly in the development of anticancer agents. Its structure is designed to interact with DNA, making it effective in targeting and inhibiting the growth of cancer cells. The compound is often studied for its potential to induce apoptosis in tumor cells, making it a candidate for chemotherapeutic applications. Additionally, it is explored for its ability to enhance the efficacy of other anticancer drugs when used in combination therapies. Research is ongoing to optimize its pharmacokinetic properties and reduce potential side effects, aiming to develop a more targeted and efficient treatment option for various types of cancer.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...